Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you treat bulky pelvic/retroperitoneal lymph nodes for prostate cancer to palliate lower extremity lymphedema?
If so, what dose do you use?
Answer from: Radiation Oncologist at Community Practice
Yes usually would use 35-40 Gy at 2.5 Gy per fraction
Sign In
or
Register
to read more
4815
Related Questions
How do you approach ADT in patients with high-risk prostate cancer who have risk factors for VTE, such as Factor V Leiden?
Does non-urothelial histology impact your approach to chemoradiotherapy for muscle-invasive bladder cancer?
What is the rationale for the recent change in the NCCN criteria for very high risk prostate cancer?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
How would you manage T3N0M0 sarcomatoid carcinoma of the prostate with adenosquamous differentiation s/p prostatectomy?
How do you manage PSA progression while a patient is on Xofigo or Pluvicto?
In light of the recent data indicating increased late grade 3 to 5 toxicities (LTOX3) after hypofractionated salvage radiation therapy, will you continue to offer these regimes to patients?
How do you design pelvic lymph node treatment volumes for patients with tortuous or aberrant vascular anatomy?
For patients starting Pluvicto, do you have patients stop their ARPI?
What are your top takeaways from ASCO GU 2025?